A detailed history of Elequin Capital LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Elequin Capital LP holds 482 shares of BSX stock, worth $41,929. This represents 0.03% of its overall portfolio holdings.

Number of Shares
482
Previous 234 105.98%
Holding current value
$41,929
Previous $18,000 122.22%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $18,094 - $20,832
248 Added 105.98%
482 $40,000
Q2 2024

Aug 12, 2024

BUY
$67.33 - $77.71 $15,755 - $18,184
234 New
234 $18,000
Q2 2022

Aug 11, 2022

SELL
$35.24 - $47.1 $2,325 - $3,108
-66 Reduced 6.59%
935 $35,000
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $40,940 - $45,145
1,001 New
1,001 $44,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Elequin Capital LP Portfolio

Follow Elequin Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Elequin Capital LP with notifications on news.